Biotricity Inc. (“Biotricity”) today announced that it has completed a series of financings that bolster the Company’s financial health, reduce execution risk, and provide it with the necessary resources to achieve profitability.  As disclosed within the financial filing of its most recent quarter, the Company added $811 thousand dollars of capital in the form of promissory and convertible promissory notes, thereby more than matching $635 thousand of additional term loan proceeds from its term loan lender.